bromocriptine has been researched along with Carcinoma, Small Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujisawa, M; Fukayama, M; Furue, H; Ishibashi, M; Maeda, Y; Yamaji, T | 1 |
| Clark, AJ; Crosby, SR; Farrell, WE; Stewart, MF; White, A | 1 |
2 other study(ies) available for bromocriptine and Carcinoma, Small Cell
| Article | Year |
|---|---|
Inhibition of growth of human small cell lung cancer by bromocriptine.
Topics: Animals; Bromocriptine; Carcinoma, Small Cell; Cell Division; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Mice; Mice, Nude; Receptors, Dopamine; Transplantation, Heterologous; Vasopressins | 1994 |
Bromocriptine inhibits pro-opiomelanocortin mRNA and ACTH precursor secretion in small cell lung cancer cell lines.
Topics: Adrenocorticotropic Hormone; Bromocriptine; Bucladesine; Carcinoma, Small Cell; Humans; Lung Neoplasms; Pro-Opiomelanocortin; Protein Precursors; RNA, Messenger; Tumor Cells, Cultured | 1992 |